Carl Adams
Comptroller/Controller/Auditor chez TELEDYNE TECHNOLOGIES INCORPORATED
Profil
Carl Adams is currently the Chief Audit Executive & Vice President at Teledyne Technologies, Inc. He previously worked as the Chief Financial Officer & Vice President at NeuroSigma, Inc. in 2014.
He completed his undergraduate degree at California State University-Northridge.
Postes actifs de Carl Adams
| Sociétés | Poste | Début |
|---|---|---|
| TELEDYNE TECHNOLOGIES INCORPORATED | Comptroller/Controller/Auditor | 01/12/2023 |
Anciens postes connus de Carl Adams
| Sociétés | Poste | Fin |
|---|---|---|
NeuroSigma, Inc.
 NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Directeur Financier/CFO | - |
Formation de Carl Adams
| California State University-Northridge | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TELEDYNE TECHNOLOGIES INCORPORATED | Electronic Technology |
| Entreprise privées | 1 |
|---|---|
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology NeuroSigma, Inc. operates as a life sciences company which develops bioelectronic technologies to treat major neurological and neuropsychiatric disorders such as epilepsy and depression. Its non-invasive external trigeminal nerve stimulation system (eTNS) employs trigeminal nerve stimulation, or TNS, as adjunctive therapy for drug-resistant epilepsy and major depressive disorder. The company was founded by Leon Ekchian in March 2008 and is headquartered in Los Angeles, CA. | Health Technology |